Trinity Biotech PLC
TRIB· Nasdaq
TRIBTrinity Biotech PLC
Source filing unavailable
| Metric | Q2 2018 | Q2 2017 |
|---|---|---|
| Revenue | $25.00M | $25.45M |
| Net Income | $594.00K | $902.00K |
| EPS Diluted | $6.70 | $6.80 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Trinity Biotech PLC · CIK 888721 · Engraved from SEC EDGAR
